Share

September 03, 2013; 81 (10) Article

Neurovascular coupling, cerebral white matter integrity, and response to cocoa in older people

Farzaneh A. Sorond, Shelley Hurwitz, David H. Salat, Douglas N. Greve, Naomi D.L. Fisher
First published August 7, 2013, DOI: https://doi.org/10.1212/WNL.0b013e3182a351aa
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
1967

Share

Article Information

vol. 81 no. 10 904-909
DOI: 
https://doi.org/10.1212/WNL.0b013e3182a351aa
PubMed: 
23925758
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received November 29, 2012
  • Accepted in final form May 6, 2013
  • First Published August 7, 2013.

Article Versions

Copyright & Usage: 
© 2013 American Academy of Neurology

Author Disclosures

    1. Farzaneh A. Sorond, MD, PhD,
    2. Shelley Hurwitz, PhD,
    3. David H. Salat, PhD,
    4. Douglas N. Greve, PhD and
    5. Naomi D.L. Fisher, MD
  1. Farzaneh A. Sorond, MD, PhD,
    2. Scientific Advisory Boards:

    1. North American Thrombosis Forum, Non-profit organization, Scientific Advisory Board 2007- present

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Supplied Cocoa

    Research Support, Government Entities:

    1. (1) NIA: PI K23-AG030967 2008-2013

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Shelley Hurwitz, PhD,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. David H. Salat, PhD,
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Janssen Pharmaceuticals

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Biogen Idec

    Research Support, Government Entities:

    1. NIHNS042861; NIHRRP4114075; NIHR21026104; NIHAG026484; NIHAG028676; R01NR010827;

    Research Support, Academic Entities:

    1. Executive Committee on Research (MGH)

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Douglas N. Greve, PhD and
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Naomi D.L. Fisher, MD
    6. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Mars Inc. supplied cocoa

    Research Support, Government Entities:

    1. NIH: NHLBI, RO1 HL089570-01, PI 01/01/09-12/31/13 NCE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Department of Neurology, Stroke Division (F.A.S.), and Department of Medicine, Division of Endocrinology, Diabetes and Hypertension (S.H., N.D.L.F.), Brigham and Women's Hospital; Neuroimaging Research for Veterans Center (D.H.S.), and Geriatric Research, Education and Clinical Center (D.H.S.), VA Boston Healthcare System; MGH/MIT/HMS Athinoula A. Martinos Center for Biomedical Imaging (D.H.S., D.N.G.), Department of Radiology, Massachusetts General Hospital; and Harvard Medical School (F.A.S., S.H., D.H.S., D.N.G., N.D.L.F.), Boston, MA.
  1. Correspondence to Dr. Sorond: fsorond{at}partners.org
View Full Text

Article usage

Article usage: August 2013 to April 2019

AbstractFullPdfSource
Aug 2013133446273Highwire
Sep 20134995162130Highwire
Oct 2013240610642Highwire
Nov 201314325032Highwire
Dec 201317927024Highwire
Jan 201413551920Highwire
Feb 20148822223Highwire
Mar 20148292621Highwire
Apr 20146792217Highwire
May 20147571116Highwire
Jun 20144381313Highwire
Jul 201435363Highwire
Aug 201479585Highwire
Sep 2014112397Highwire
Oct 20147061013Highwire
Nov 20144951111Highwire
Dec 2014411113Highwire
Jan 201536967Highwire
Jan 20150357pmc
Feb 2015343103Highwire
Feb 201504313pmc
Mar 201538155Highwire
Mar 201505229pmc
Apr 201543412Highwire
Apr 20150357pmc
May 201532931Highwire
May 201503114pmc
Jun 201541057Highwire
Jun 201503016pmc
Jul 201528633Highwire
Jul 20150208pmc
Aug 201525668Highwire
Aug 20150202pmc
Sep 201545267Highwire
Sep 201502811pmc
Oct 20153511015Highwire
Oct 2015017714pmc
Nov 2015283727Highwire
Nov 201503213pmc
Dec 201519998Highwire
Dec 20150459pmc
Jan 201635815Highwire
Jan 20160438pmc
Feb 201632752Highwire
Feb 201604416pmc
Mar 201633573Highwire
Mar 20160409pmc
Apr 201628821Highwire
Apr 201602712pmc
May 201628811Highwire
May 20160319pmc
Jun 201624300Highwire
Jun 201603417pmc
Jul 201619601Highwire
Jul 20160272pmc
Aug 201626901Highwire
Aug 20160217pmc
Sep 2016293113Highwire
Sep 20160196pmc
Oct 201628814204Highwire
Oct 20160334pmc
Nov 2016269417Highwire
Nov 20160175pmc
Dec 201633404Highwire
Dec 20160193pmc
Jan 201735002Highwire
Jan 201703311pmc
Feb 201747000Highwire
Feb 201703511pmc
Mar 201735923Highwire
Mar 20170238pmc
Apr 201733611Highwire
Apr 2017183841pmc
May 201736800Highwire
May 201792733pmc
Jun 201722001Highwire
Jun 201772842pmc
Jul 201724901Highwire
Jul 201762632pmc
Aug 201722313Highwire
Aug 2017142736pmc
Sep 2017251226Highwire
Sep 201741818pmc
Oct 201731813182Highwire
Oct 2017123239pmc
Nov 2017367621Highwire
Nov 2017174245pmc
Dec 2017295261Highwire
Jan 201833220Highwire
Feb 201829831Highwire
Mar 201838256Highwire
Apr 201838323Highwire
Apr 201893440pmc
May 201833301Highwire
Jun 201831420Highwire
Jun 201862434pmc
Jul 201827310Highwire
Aug 201821232Highwire
Aug 2018112641pmc
Sep 2018195319Highwire
Oct 201830721628Highwire
Nov 201836951Highwire
Dec 201825962Highwire
Jan 201930130Highwire
Feb 201919120Highwire
Mar 201927113Highwire
Apr 201928300Highwire

Cited By...

Disputes & Debates: Rapid online correspondence

Comment

NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.

  • Stay timely. Submit only on articles published within the last 8 weeks.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • 200 words maximum.
  • 5 references maximum. Reference 1 must be the article on which you are commenting.
  • 5 authors maximum. Exception: replies can include all original authors of the article.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Disputes & Debates Submission Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

More Online

CME Course

Related Articles

Topics Discussed

Alert Me